{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:14:21Z","timestamp":1792120461386,"version":"4.4.0"},"reference-count":410,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/23710-8"],"award-info":[{"award-number":["2024\/23710-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2023\/01664-1"],"award-info":[{"award-number":["2023\/01664-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2020\/16573-3"],"award-info":[{"award-number":["2020\/16573-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005430","name":"American Society for Microbiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005430","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PE501092284-2024"],"award-info":[{"award-number":["PE501092284-2024"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pharmr.2025.100104","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:10:54Z","timestamp":1763183454000},"page":"100104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0383","authenticated-orcid":false,"given":"Cesar Augusto","family":"Roque-Borda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2325-6745","authenticated-orcid":false,"given":"Thi Phuong Truc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thu Hoai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-6327","authenticated-orcid":false,"given":"Himadri","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor Leoc\u00e1dio de Souza","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Canales Carnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-4975","authenticated-orcid":false,"given":"Darcy","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3788-3372","authenticated-orcid":false,"given":"Naiera M.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-3826","authenticated-orcid":false,"given":"Prasanna Babu","family":"Araveti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz G.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Albericio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Rog\u00e9rio","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.07.010","article-title":"Antimicrobial resistance: a concise update","volume":"6","author":"Ho","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410893","article-title":"Antimicrobial peptides: a promising alternative to conventional antimicrobials for combating polymicrobial biofilms","volume":"12","author":"Roque-Borda","year":"2024","journal-title":"Adv Sci"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1017\/ice.2022.256","article-title":"Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad","volume":"44","author":"Bopp","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib5","series-title":"WHO Strategic Priorities on Antimicrobial Resistance","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100104_bib6","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"26","key":"10.1016\/j.pharmr.2025.100104_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300472","article-title":"Antimicrobial peptide synergies for fighting infectious diseases","volume":"10","author":"Mhlongo","year":"2023","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/fermentation11010036","article-title":"Antimicrobial peptides, their production, and potential in the fight against antibiotic-resistant pathogens","volume":"11","author":"Saubenova","year":"2025","journal-title":"Fermentation"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/ph18101440","article-title":"Peptide-based strategies against Mycobacterium tuberculosis covering immunomodulation, vaccines, synergistic therapy, and nanodelivery","volume":"18","author":"Roque-Borda","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib11","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1038\/s41598-025-93683-1","article-title":"Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights","volume":"15","author":"Dermawan","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31958","article-title":"Recent advances in the development of antimicrobial peptides against ESKAPE pathogens","volume":"10","author":"Roque-Borda","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib13","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1038\/s41467-020-18939-y","article-title":"Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00203-024-04152-8","article-title":"The clinical praxis of bacteriocins as natural anti-microbial therapeutics","volume":"206","author":"Nisar","year":"2024","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib15","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1038\/s41467-024-51730-x","article-title":"Synergistic collaboration between AMPs and non-direct antimicrobial cationic peptides","volume":"15","author":"Ye","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100104_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1183247","article-title":"Antimicrobial peptides as drugs with double response against Mycobacterium tuberculosis coinfections in lung cancer","volume":"14","author":"Polin\u00e1rio","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple Fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib18","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.bbamem.2018.06.004","article-title":"Bactericidal activity of amphipathic cationic antimicrobial peptides involves altering the membrane fluidity when interacting with the phospholipid bilayer","volume":"1860","author":"Omardien","year":"2018","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41564-024-01696-9","article-title":"hosts. Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism","volume":"9","author":"Jekhmane","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.598789","article-title":"Isolation, characterization and structure elucidation of a novel lantibiotic from Paenibacillus sp","volume":"11","author":"Karczewski","year":"2020","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1134\/S0003683823603104","article-title":"Mechanisms of action, biological characteristics, and future prospects: a review of antimicrobial peptides (A review)","volume":"60","author":"Ma","year":"2024","journal-title":"Appl Biochem Microbiol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.chembiol.2018.02.004","article-title":"The dolphin proline-rich antimicrobial peptide Tur1A inhibits protein synthesis by targeting the bacterial ribosome","volume":"25","author":"Mardirossian","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib23","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s10904-019-01427-2","article-title":"Photochemically-generated silver chloride nanoparticles stabilized by a peptide inhibitor of cell division and its antimicrobial properties","volume":"30","author":"Cruz","year":"2020","journal-title":"J Inorg Organomet Polym Mater"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3382\/ps\/pew379","article-title":"Effects of antimicrobial peptides on growth performance and small intestinal function in broilers under chronic heat stress","volume":"96","author":"Hu","year":"2017","journal-title":"Poult Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib25","article-title":"A systematic review of the design and applications of antimicrobial peptides in wound healing","volume":"16","author":"Ahmad","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib26","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41396-019-0483-z","article-title":"Selection for antimicrobial resistance is reduced when embedded in a natural microbial community","volume":"13","author":"Kl\u00fcmper","year":"2019","journal-title":"ISME J"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1071\/MA24021","article-title":"Introducing CRC SAAFE: a new Cooperative Research Centre (CRC) focused on managing AMR in agriculture and the environment","volume":"45","author":"Donner","year":"2024","journal-title":"Microbiol Aust"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00775-022-01983-y","article-title":"Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria","volume":"28","author":"Zhang","year":"2023","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.pharmr.2025.100104_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2024.102562","article-title":"Bacterial peptidoglycan as a living polymer","volume":"84","author":"El-Araby","year":"2025","journal-title":"Curr Opin Chem Biol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41579-018-0030-3","article-title":"Feasting on \u03b2-lactams","volume":"16","author":"Hofer","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib31","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ddr.21990","article-title":"Beta-lactam resistance and the effectiveness of antimicrobial peptides against KPC-producing bacteria","volume":"83","author":"da Costa de Souza","year":"2022","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcp.2016.10.001","article-title":"History of antimicrobial drug discovery: major classes and health impact","volume":"133","author":"Aminov","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1039\/b613652b","article-title":"Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis","volume":"24","author":"Kopp","year":"2007","journal-title":"Nat Prod Rep"},{"issue":"45","key":"10.1016\/j.pharmr.2025.100104_bib34","doi-asserted-by":"crossref","first-page":"E7077","DOI":"10.1073\/pnas.1611173113","article-title":"Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains","volume":"113","author":"M\u00fcller","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100104_bib35","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1039\/C4CS00426D","article-title":"A comprehensive review of glycosylated bacterial natural products","volume":"44","author":"Elshahawi","year":"2015","journal-title":"Chem Soc Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2478\/bvip-2014-0095","article-title":"Amphenicols stability in medicated feed\u2014development and validation of liquid chromatography method","volume":"58","author":"Pietro","year":"2014","journal-title":"Bull Vet Inst Pulawy"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100104_bib38","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100104_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2016.12.001","article-title":"Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications","volume":"133","author":"Sp\u00ed\u017eek","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib40","article-title":"Current updates on oxazolidinone and its significance","volume":"2012","author":"Pandit","year":"2012","journal-title":"Int J Med Chem"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib41","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2018.08.028","article-title":"Mode of action of Kanglemycin A, an ansamycin natural product that is active against rifampicin-resistant Mycobacterium tuberculosis","volume":"72","author":"Mosaei","year":"2018","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12915-018-0534-3","article-title":"A bacterial route for folic acid supplementation","volume":"16","author":"Maynard","year":"2018","journal-title":"BMC Biol"},{"issue":"20","key":"10.1016\/j.pharmr.2025.100104_bib44","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1007\/s00253-018-9266-0","article-title":"Formation of folates by microorganisms: towards the biotechnological production of this vitamin","volume":"102","author":"Revuelta","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jor.23656","article-title":"Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections","volume":"36","author":"Li","year":"2018","journal-title":"J Orthop Res"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119417119","article-title":"Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127363","article-title":"Microbial lipopeptides: properties, mechanics and engineering for novel lipopeptides","volume":"271","author":"Sreedharan","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1269392","article-title":"A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA","volume":"14","author":"Jalalifar","year":"2024","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib51","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/antibiotics11111516","article-title":"Bioengineered nisin A derivatives display enhanced activity against clinical neonatal pathogens","volume":"11","author":"Desmond","year":"2022","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib52","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsinfecdis.0c00016","article-title":"Combined efficacy of an antimicrobial cationic peptide polymer with conventional antibiotics to combat multidrug-resistant pathogens","volume":"6","author":"Thappeta","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib53","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/jac\/dku049","article-title":"Nisin\/\u03b2-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach","volume":"69","author":"Singh","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1946","article-title":"\u03a976: a designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii","volume":"5","author":"Nagarajan","year":"2019","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07388551.2011.594423","article-title":"Antimicrobial peptides: key components of the innate immune system","volume":"32","author":"Pasupuleti","year":"2012","journal-title":"Crit Rev Biotechnol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126953","article-title":"Defensing role of novel piscidins from largemouth bass (Micropterus salmoides) with evidence of bactericidal activities and inducible expressional delineation","volume":"256","author":"Duan","year":"2022","journal-title":"Microbiol Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149452","article-title":"Effect of membrane tension on antimicrobial peptide PGLa-induced pore formation in lipid bilayers","volume":"695","author":"Ahmed","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100104_bib59","article-title":"New strategies and mechanisms for targeting Streptococcus mutans biofilm formation to prevent dental caries: a review","volume":"278","author":"Gao","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127417","article-title":"Strategies adopted by gastric pathogen Helicobacter pylori for a mature biofilm formation: antimicrobial peptides as a visionary treatment","volume":"273","author":"Gupta","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104700","article-title":"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates","volume":"150","author":"Jahangiri","year":"2021","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41522-024-00560-2","article-title":"Microbiome-derived antimicrobial peptides show therapeutic activity against the critically important priority pathogen, Acinetobacter baumannii","volume":"10","author":"Alexander","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/antibiotics12020389","article-title":"Synergy between human peptide LL-37 and polymyxin B against planktonic and biofilm cells of Escherichia coli and Pseudomonas aeruginosa","volume":"12","author":"Ridyard","year":"2023","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib64","doi-asserted-by":"crossref","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC\u2212, and carbapenemase-producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib65","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s42003-022-03899-4","article-title":"The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections","volume":"5","author":"Shi","year":"2022","journal-title":"Commun Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib66","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","article-title":"Antibiotic potentiation in multidrug-resistant Gram-negative pathogenic bacteria by a synthetic peptidomimetic","volume":"7","author":"Mood","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100104_bib67","article-title":"Synergistic antimicrobial effect of antimicrobial peptides CATH-1, CATH-3, and PMAP-36 with erythromycin against bacterial pathogens","volume":"13","author":"Lu","year":"2022","journal-title":"Front Microbiol"},{"issue":"13","key":"10.1016\/j.pharmr.2025.100104_bib68","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3390\/ijms21134578","article-title":"Antimicrobial peptides display strong synergy with vancomycin against vancomycin-resistant E. faecium, S. aureus, and wild-type E. coli","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12866-023-02881-2","article-title":"Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms","volume":"23","author":"Lu","year":"2023","journal-title":"BMC Microbiol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib70","doi-asserted-by":"crossref","DOI":"10.1116\/6.0001981","article-title":"New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation","volume":"17","author":"Han","year":"2022","journal-title":"Biointerphases"},{"key":"10.1016\/j.pharmr.2025.100104_bib71","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3389\/fmicb.2019.02740","article-title":"Synergy pattern of short cationic antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Ruden","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.591426","article-title":"High-throughput identification of antibacterials against Pseudomonas aeruginosa","volume":"11","author":"Li","year":"2020","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib73","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/jac\/dkac204","article-title":"Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase","volume":"77","author":"Mullally","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib74","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41429-018-0090-7","article-title":"Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus","volume":"71","author":"Shurko","year":"2018","journal-title":"J Antibiot"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib75","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1039\/D3NA00620D","article-title":"Antimicrobial peptide-conjugated phage-mimicking nanoparticles exhibit potent bactericidal action against Streptococcus pyogenes in murine wound infection models","volume":"6","author":"Olesk","year":"2024","journal-title":"Nanoscale Adv"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00497-22","article-title":"Antimicrobial activity of peptide-coupled antisense peptide nucleic acids in Streptococcus pneumoniae","volume":"10","author":"Barkowsky","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.pharmr.2025.100104_bib77","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3887","article-title":"Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from indolicidin and ranalexin against Streptococcus pneumoniae","volume":"5","author":"Jindal","year":"2017","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10989-023-10561-y","article-title":"Antibiotic-peptide conjugation against multi-drug resistant pathogens: a comprehensive review for therapeutics and drug delivery strategies","volume":"29","author":"Kalimuthu","year":"2023","journal-title":"Int J Pept Res Ther"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib79","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/pharmaceutics13111800","article-title":"Development of novel peptides for the antimicrobial combination therapy against carbapenem-resistant Acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib80","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1021\/acsinfecdis.4c00160","article-title":"Deciphering the intracellular action of the antimicrobial peptide A11 via an in-depth analysis of its effect on the global proteome of Acinetobacter baumannii","volume":"10","author":"Thitirungreangchai","year":"2024","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100104_bib81","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/IDR.S215084","article-title":"Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"12","author":"Swedan","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12941-017-0249-2","article-title":"Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review","volume":"16","author":"Jacobs","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib83","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41598-021-81140-8","article-title":"In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli","volume":"11","author":"Witherell","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100104_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1153868","article-title":"Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae","volume":"13","author":"Chatupheeraphat","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105056","article-title":"Synergistic effect and antibiofilm activity of an antimicrobial peptide with traditional antibiotics against multi-drug resistant bacteria","volume":"158","author":"Duan","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.pharmr.2025.100104_bib86","article-title":"Significance of LL-37 on immunomodulation and disease outcome","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.pharmr.2025.100104_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105403","article-title":"Synergistic activity and immunomodulatory potential of levofloxacin and Synoeca-MP peptide against multi-resistant strains of Klebsiella pneumoniae","volume":"163","author":"Ormondes de Farias","year":"2022","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib88","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s10096-017-2987-7","article-title":"Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains","volume":"36","author":"Morici","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib89","doi-asserted-by":"crossref","first-page":"e00359","DOI":"10.1128\/AAC.00359-18","article-title":"Synergy between circular bacteriocin AS-48 and ethambutol against mycobacterium tuberculosis","volume":"62","author":"Aguilar-P\u00e9rez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib90","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/antibiotics11121785","article-title":"In vitro antimycobacterial activity of human lactoferrin-derived peptide, D-hLF 1\u201311, against susceptible and drug-resistant Mycobacterium tuberculosis and its synergistic effect with rifampicin","volume":"11","author":"Intorasoot","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.pharmr.2025.100104_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123960","article-title":"Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis","volume":"654","author":"Shao","year":"2024","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib92","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1038\/s41598-021-83755-3","article-title":"A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy","volume":"11","author":"Rao","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib93","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/ijms25010407","article-title":"Absence of synergism between a dual-AMP biogel and antibiotics used as therapeutic agents for diabetic foot infections","volume":"25","author":"Soares","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294287","article-title":"Synergistic effect of two antimicrobial peptides, BP 203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates","volume":"18","author":"Chatupheeraphat","year":"2023","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib96","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib97","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3390\/ijms22063128","article-title":"Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors","volume":"22","author":"Jurado-Mart\u00edn","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib98","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","article-title":"Carbapenemase-producing Pseudomonas aeruginosa \u2013an emerging challenge","volume":"11","author":"Tenover","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10096-014-2219-3","article-title":"Functional synergy of \u03b1-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo","volume":"34","author":"Feng","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib101","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/acsinfecdis.9b00164","article-title":"Antagonizing vancomycin resistance in Enterococcus by surface localized antimicrobial display-derived peptides","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"24","key":"10.1016\/j.pharmr.2025.100104_bib102","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2174\/1568026619666181219123431","article-title":"Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa Sepsis","volume":"18","author":"Cirioni","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220000","article-title":"Diabetic foot infections: application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms","volume":"14","author":"Santos","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib104","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1534734618757532","article-title":"Local antibiotic delivery systems: current and future applications for diabetic foot infections","volume":"17","author":"Markakis","year":"2018","journal-title":"Int J Low Extrem Wounds"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib105","article-title":"Topical antimicrobial agents for treating foot ulcers in people with diabetes","volume":"6","author":"Dumville","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib106","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1128\/AAC.04773-14","article-title":"In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms","volume":"59","author":"Flamm","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib107","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1365-2672.2008.03942.x","article-title":"A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses","volume":"105","author":"Willcox","year":"2008","journal-title":"J Appl Microbiol"},{"issue":"17","key":"10.1016\/j.pharmr.2025.100104_bib108","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/molecules25173843","article-title":"Activity of antimicrobial peptides and ciprofloxacin against Pseudomonas aeruginosa biofilms","volume":"25","author":"Yasir","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100104_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1030401","article-title":"Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and\u2014Pseudomonas aeruginosa","volume":"14","author":"Mirzaei","year":"2023","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib111","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/cid\/ciz977","article-title":"National trends in incidence of purulent skin and soft tissue infections in patients presenting to ambulatory and emergency department settings, 2000\u20132015","volume":"70","author":"Fritz","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib112","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2009.09.001","article-title":"Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus","volume":"59","author":"Fritz","year":"2009","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.idc.2015.05.007","article-title":"Prevention of recurrent staphylococcal skin infections","volume":"29","author":"Creech","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmi.2024.01.003","article-title":"Eradication of community-onset methicillin-resistant Staphylococcus aureus carriage: a narrative review","volume":"31","author":"Westgeest","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/bta.2024.139756","article-title":"Genetics of antibiotic resistance in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"105","author":"Marciniak","year":"2024","journal-title":"Biotechnologia"},{"key":"10.1016\/j.pharmr.2025.100104_bib116","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/IDR.S510024","article-title":"Staphylococcal drug resistance: mechanisms, therapies, and nanoparticle interventions","volume":"18","author":"Shao","year":"2025","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib117","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/ijms21031061","article-title":"Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib118","doi-asserted-by":"crossref","first-page":"e00829","DOI":"10.1128\/AAC.00829-20","article-title":"Successful development of bacteriocins into therapeutic formulation for treatment of MRSA skin infection in a murine model","volume":"64","author":"Ovchinnikov","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pharmr.2025.100104_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676534","article-title":"A strong synergy between the thiopeptide bacteriocin micrococcin P1 and rifampicin against MRSA in a murine skin infection model","volume":"12","author":"Ovchinnikov","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1039\/b919071f","article-title":"Micrococcin P1: structure, biology and synthesis","volume":"27","author":"Ciufolini","year":"2010","journal-title":"Nat Prod Rep"},{"issue":"17","key":"10.1016\/j.pharmr.2025.100104_bib121","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1128\/AEM.01094-16","article-title":"Novel group of leaderless multipeptide bacteriocins from Gram-positive bacteria","volume":"82","author":"Ovchinnikov","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103712","article-title":"Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues","volume":"136","author":"Zhou","year":"2019","journal-title":"Microb Pathog"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib123","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s11274-014-1739-4","article-title":"Synergistic interaction of PMAP-36 and PRW4 with aminoglycoside antibiotics and their antibacterial mechanism","volume":"30","author":"Wang","year":"2014","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100104_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572849","article-title":"The synergistic effect of mud crab antimicrobial peptides Sphistin and Sph12\u221238 with antibiotics azithromycin and rifampicin enhances bactericidal activity against Pseudomonas aeruginosa","volume":"10","author":"Liu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib125","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.2147\/DMSO.S435062","article-title":"Antibacterial activity of surfactin and synergistic effect with conventional antibiotics against methicillin-resistant Staphylococcus aureus isolated from patients with diabetic foot ulcers","volume":"16","author":"Li","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40360-021-00503-z","article-title":"In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria","volume":"22","author":"Askari","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib127","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s42770-021-00635-8","article-title":"Antimicrobial resistance in the globalized food chain: a One Health perspective applied to the poultry industry","volume":"53","author":"de Mesquita Souza Saraiva","year":"2022","journal-title":"Braz J Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib128","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1469-0691.2012.03829.x","article-title":"Enterococci of animal origin and their significance for public health","volume":"18","author":"Hammerum","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/acsinfecdis.1c00264","article-title":"HPMCAS-coated alginate microparticles loaded with CTX(Ile21)-ha as a promising antimicrobial agent against Salmonella enteritidis in a chicken infection model","volume":"8","author":"Roque-Borda","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100104_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100248","article-title":"Essential oils used in the poultry industry: would it be an effective green alternative against Salmonella spp. dissemination and antimicrobial resistance?","volume":"6","author":"Rodrigues","year":"2025","journal-title":"Microb"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib131","doi-asserted-by":"crossref","DOI":"10.1093\/lambio\/ovae071","article-title":"Competitive exclusion products as an antimicrobial alternative to control Salmonella Heidelberg in broilers","volume":"77","author":"Kolososki","year":"2024","journal-title":"Lett Appl Microbiol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib132","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41579-024-01058-6","article-title":"Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics","volume":"22","author":"Wei","year":"2024","journal-title":"Nat Rev Microbio"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib133","first-page":"507","article-title":"Isolation, characterization, and efficacy of three lytic phages infecting multidrug-resistant salmonella serovars from poultry FARMS in Egypt","volume":"76","author":"Sobhy","year":"2021","journal-title":"Arch Razi Inst"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib134","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.drudis.2018.01.026","article-title":"Phage-derived lysins as potential agents for eradicating biofilms and persisters","volume":"23","author":"Sharma","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmr.2025.100104_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.615887","article-title":"Development of a novel chimeric endolysin, Lys109 with enhanced lytic activity against Staphylococcus aureus","volume":"11","author":"Son","year":"2021","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib136","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/antibiotics10091116","article-title":"Alternatives to fight vancomycin-resistant staphylococci and enterococci","volume":"10","author":"Ba\u00ebtz","year":"2021","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib137","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S2666-5247(23)00318-X","article-title":"Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review","volume":"5","author":"Smeesters","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3446","article-title":"Synergistic effects of short peptides and antibiotics against bacterial and fungal strains","volume":"29","author":"Sharma","year":"2023","journal-title":"J Pept Sci"},{"key":"10.1016\/j.pharmr.2025.100104_bib139","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics-a novel way to combat antibiotic resistance?","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1390765","article-title":"Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions","volume":"15","author":"Taheri-Araghi","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2021.640981","article-title":"Developing antimicrobial synergy with AMPs","volume":"3","author":"Duong","year":"2021","journal-title":"Front Med Technol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib142","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/AAC.00273-11","article-title":"In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella","volume":"55","author":"Rishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"10.1016\/j.pharmr.2025.100104_bib143","doi-asserted-by":"crossref","first-page":"16854","DOI":"10.1021\/acs.jmedchem.1c01712","article-title":"Multifunctional antibiotic\u2013host defense peptide conjugate kills bacteria, eradicates biofilms, and modulates the innate immune response","volume":"64","author":"Etayash","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100104_bib144","unstructured":"Spellerberg B, Brandt C. Laboratory diagnosis of Streptococcus pyogenes (group A streptococci). In: Ferretti JJ, Stevens DL, Fischetti VA, eds. Streptococcus Pyogenes: Basic Biology to Clinical Manifestations. 2nd ed. University of Oklahoma Health Sciences Center; 2022."},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib145","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/microorganisms10122316","article-title":"An overview of macrolide resistance in streptococci: prevalence, mobile elements and dynamics","volume":"10","author":"Berbel","year":"2022","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib146","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104609","article-title":"Global genomic epidemiology of Streptococcus pyogenes","volume":"86","author":"Jespersen","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib148","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pathogens10020248","article-title":"A review of Streptococcus pyogenes: public health risk factors, prevention and control","volume":"10","author":"Avire","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.pharmr.2025.100104_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105258","article-title":"A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: a systematic review","volume":"99","author":"Rafei","year":"2022","journal-title":"Infect Genet Evol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100104_bib151","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jgar.2020.02.005","article-title":"Distribution of emm types and macrolide resistance determinants among group A streptococci in the Middle East and North Africa region","volume":"22","author":"Rafei","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.pharmr.2025.100104_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by Group A Streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib153","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.omtn.2019.09.010","article-title":"Influence of different cell-penetrating peptides on the antimicrobial efficiency of PNAs in Streptococcus pyogenes","volume":"18","author":"Barkowsky","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib154","article-title":"Inhibition of growth and gene expression by PNA-peptide conjugates in Streptococcus pyogenes","volume":"2","author":"Patenge","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib155","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00028-21","article-title":"Invasive Haemophilus influenzae infections after 3 decades of Hib protein conjugate vaccine use","volume":"34","author":"Slack","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib156","article-title":"Epidemiology and population structure of Haemophilus influenzae causing invasive disease","volume":"7","author":"Carrera-Salinas","year":"2021","journal-title":"Microb Genom"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib157","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jiph.2019.11.003","article-title":"\u03b2-lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance","volume":"13","author":"Yamada","year":"2020","journal-title":"J Infect Public Health"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib158","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S1473-3099(23)00188-3","article-title":"Trends in invasive Haemophilus influenzae serotype a disease in England from 2008\u201309 to 2021\u201322: a prospective national surveillance study","volume":"23","author":"Bertran","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pharmr.2025.100104_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.973257","article-title":"Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017\u20132021","volume":"13","author":"T\u00f8nnessen","year":"2022","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib160","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijmmb.2021.09.001","article-title":"Antimicrobial resistance of Haemophilus influenzae isolates from pediatric hospitals in Mainland China: report from the ISPED program, 2017\u20132019","volume":"39","author":"Zhou","year":"2021","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib161","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-023-08930-5","article-title":"First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysis","volume":"24","author":"Abavisani","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib162","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13073-024-01406-4","article-title":"Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae","volume":"16","author":"Diricks","year":"2024","journal-title":"Genome Med"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib163","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00203-024-04196-w","article-title":"Potential role of the antimicrobial peptide tachyplesin III in regulating nontypeable Haemophilus influenzae-induced inflammation in airway epithelial cells","volume":"206","author":"Jantaruk","year":"2024","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib164","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2172-13-24","article-title":"Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae","volume":"13","author":"Augustyniak","year":"2012","journal-title":"BMC Immunol"},{"issue":"52","key":"10.1016\/j.pharmr.2025.100104_bib165","doi-asserted-by":"crossref","first-page":"33507","DOI":"10.1073\/pnas.2010428117","article-title":"An in vivo atlas of host-pathogen transcriptomes during Streptococcus pneumoniae colonization and disease","volume":"117","author":"D\u2019Mello","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2025.100104_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638917","article-title":"Characterization of the anti-inflammatory capacity of IL-10-producing neutrophils in response to Streptococcus pneumoniae infection","volume":"12","author":"Gonz\u00e1lez","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100104_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.643326","article-title":"Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae","volume":"11","author":"Sender","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127221","article-title":"Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review","volume":"266","author":"Li","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.737396","article-title":"The pneumococcal divisome: dynamic control of Streptococcus pneumoniae cell division","volume":"12","author":"Briggs","year":"2021","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib170","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib171","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1165\/rcmb.2007-0328OC","article-title":"Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection","volume":"39","author":"Xu","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib172","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/intimm\/dxn071","article-title":"Contribution of IL-1 to resistance to Streptococcus pneumoniae infection","volume":"20","author":"Kafka","year":"2008","journal-title":"Int Immunol"},{"issue":"52","key":"10.1016\/j.pharmr.2025.100104_bib173","doi-asserted-by":"crossref","first-page":"33561","DOI":"10.1073\/pnas.2015368117","article-title":"Macrophage LC3-associated phagocytosis is an immune defense against Streptococcus pneumoniae that diminishes with host aging","volume":"117","author":"Inomata","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib174","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2009.10.002","article-title":"Of mice and men: innate immunity in pneumococcal pneumonia","volume":"35","author":"Calbo","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib175","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00546-22","article-title":"Characterization of Streptococcus pneumoniae macrolide resistance and its mechanism in Northeast China over a 20-year period","volume":"10","author":"Zhou","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib176","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21315\/mjms2024.31.2.17","article-title":"Detection of macrolide-resistant Streptococcus pneumoniae Genes and Its clinical outcomes in a Tertiary Teaching Hospital in Malaysia","volume":"31","author":"Wan Mahmud","year":"2024","journal-title":"Malays J Med Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib177","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/medicina59111927","article-title":"A review of the resistance mechanisms for \u03b2-lactams, macrolides and fluoroquinolones among Streptococcus pneumoniae","volume":"59","author":"Zahari","year":"2023","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib178","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1073\/pnas.1915812117","article-title":"Designing cyclic competence-stimulating peptide (CSP) analogs with pan-group quorum-sensing inhibition activity in Streptococcus pneumoniae","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib179","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/febs.15514","article-title":"Structure-based design of peptides that trigger Streptococcus pneumoniae cell death","volume":"288","author":"Kang","year":"2021","journal-title":"FEBS Journal"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268262","article-title":"Molecular typing and prevalence of antibiotic resistance and virulence genes in Streptococcus agalactiae isolated from Chinese dairy cows with clinical mastitis","volume":"17","author":"Han","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100104_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.647324","article-title":"Multidrug resistance and molecular characterization of Streptococcus agalactiae isolates from dairy cattle with mastitis","volume":"11","author":"Hernandez","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib182","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2180938","article-title":"Fructose promotes ampicillin killing of antibiotic-resistant Streptococcus agalactiae","volume":"14","author":"Chen","year":"2023","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303271","article-title":"Identification of antibiotic induced persister cells in Streptococcus agalactiae","volume":"19","author":"Greve","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib184","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2379862","article-title":"Neonatal intestinal colonization of Streptococcus agalactiae and the multiple modes of protection limiting translocation","volume":"16","author":"Greenfield","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.pharmr.2025.100104_bib185","article-title":"To screen or not to screen women for Group B Streptococcus (Streptococcus agalactiae) to prevent early onset sepsis in newborns: recent advances in the unresolved debate","volume":"7","author":"Rao","year":"2020","journal-title":"Ther Adv Infect Dis"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib186","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10096-020-03992-8","article-title":"Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in eastern Sicily (Italy)","volume":"39","author":"Genovese","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib187","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.pharmr.2025.100104_bib188","article-title":"Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China","volume":"14","author":"Liu","year":"2023","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib189","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.22207\/JPAM.15.3.43","article-title":"Prevalence, resistance profile and virulence genes of Streptococcus agalactiae colonizing near-term pregnant women attending Ain Shams University Hospital","volume":"15","author":"Abdallah","year":"2021","journal-title":"J Pure Appl Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib190","first-page":"650","article-title":"Incidence of virulence determinants among Streptococcus agalactiae isolated from pregnant women and association with their serotypes","volume":"10","author":"EL-Lakany","year":"2023","journal-title":"Egypt J Basic Appl Sci"},{"key":"10.1016\/j.pharmr.2025.100104_bib191","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.593356","article-title":"Streptococcal serine-rich repeat proteins in colonization and disease","volume":"11","author":"Chan","year":"2020","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib192","article-title":"A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains","volume":"3","author":"Pawlowski","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7329","article-title":"Nanotechnology, a novel strategy in detecting Streptococcus agalactiae, and its antibacterial, antibiofilm, and antiquorum sensing properties","volume":"38","author":"Dousari","year":"2024","journal-title":"Appl Organomet Chem"},{"key":"10.1016\/j.pharmr.2025.100104_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5573345","article-title":"Is penicillin-nonsusceptible Streptococcus pneumoniae a significant challenge to healthcare system? A systematic review and meta-analysis","volume":"2021","author":"Khademi","year":"2021","journal-title":"Scientifica"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib195","first-page":"266","article-title":"Resistance to \u03b2-lactams in Streptococcus pneumoniae","volume":"53","author":"von Specht","year":"2021","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib196","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbrc.2022.02.061","article-title":"Antibacterial effect of synthetic ultra-short lipopeptide on Streptococcus agalactiae and its active on bacterial mastitis in mice","volume":"601","author":"Peng","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"40","key":"10.1016\/j.pharmr.2025.100104_bib197","doi-asserted-by":"crossref","first-page":"44459","DOI":"10.1021\/acsami.0c12226","article-title":"Targeted and intracellular antibacterial activity against S. agalactiae of the chimeric peptides based on pheromone and cell-penetrating peptides","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib198","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/microorganisms10050881","article-title":"In vitro pharmacodynamics and bactericidal mechanism of fungal defensin-derived peptides NZX and P2 against Streptococcus agalactiae","volume":"10","author":"Wu","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.pharmr.2025.100104_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"J Med Surg Public Health"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/antibiotics10060650","article-title":"The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent","volume":"10","author":"Ridyard","year":"2021","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib201","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","article-title":"Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances","volume":"17","author":"Baral","year":"2025","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib202","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/pharmaceutics12090840","article-title":"An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections","volume":"12","author":"Patrulea","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2025.100104_bib203","article-title":"Potency of all-D amino acid antimicrobial peptides derived from the bovine rumen microbiome on tuberculous and non-tuberculous mycobacteria","volume":"8","author":"Boidin-Wichlacz","year":"2025","journal-title":"Curr Res Microb Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib204","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/biom11111716","article-title":"D-amino acids and D-amino acid-containing peptides: potential disease biomarkers and therapeutic targets?","volume":"11","author":"Abdulbagi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2025.100104_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114502","article-title":"Strategies and progresses for enhancing targeted antibiotic delivery","volume":"189","author":"Nazli","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmr.2025.100104_bib206","article-title":"Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib207","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70072","article-title":"AI methods for antimicrobial peptides: progress and challenges","volume":"18","author":"Brizuela","year":"2025","journal-title":"Microb Biotechnol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib208","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/antibiotics13111042","article-title":"Antimicrobial peptide delivery systems as promising tools against resistant bacterial infections","volume":"13","author":"de Oliveira","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.pharmr.2025.100104_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2024.101953","article-title":"Bioactive compound encapsulation: characteristics, applications in food systems, and implications for human health","volume":"24","author":"Rezagholizade-shirvan","year":"2024","journal-title":"Food Chem X"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib210","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/antibiotics13090794","article-title":"Antimicrobial peptides and their biomedical applications: a review","volume":"13","author":"Min","year":"2024","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib211","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/antibiotics12061037","article-title":"Biological function of antimicrobial peptides on suppressing pathogens and improving host immunity","volume":"12","author":"Lyu","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib212","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12951-023-02223-4","article-title":"Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies","volume":"21","author":"Yu","year":"2023","journal-title":"J Nanobiotechnology"},{"issue":"20","key":"10.1016\/j.pharmr.2025.100104_bib213","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3390\/molecules28207165","article-title":"Peptides as therapeutic agents: challenges and opportunities in the green transition era","volume":"28","author":"Rossino","year":"2023","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib214","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/antibiotics13050439","article-title":"AMPs as host-directed immunomodulatory agents against skin infections caused by opportunistic bacterial pathogens","volume":"13","author":"Saha","year":"2024","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib215","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1074\/jbc.M111.303602","article-title":"Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions","volume":"287","author":"Yin","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib216","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.synbio.2021.01.001","article-title":"Chemical modifications of proteins and their applications in metalloenzyme studies","volume":"6","author":"Naowarojna","year":"2021","journal-title":"Synth Syst Biotechnol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib217","article-title":"Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections","volume":"11","author":"Georgakopoulou","year":"2024","journal-title":"J Biol Methods"},{"key":"10.1016\/j.pharmr.2025.100104_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1425952","article-title":"Editorial: antimicrobial peptides and their druggability, bio-safety, stability, and resistance","volume":"15","author":"Ma","year":"2024","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib219","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-023-37003-z","article-title":"Efficient in planta production of amidated antimicrobial peptides that are active against drug-resistant ESKAPE pathogens","volume":"14","author":"Chaudhary","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib220","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/pbi.14344","article-title":"Molecular farming for sustainable production of clinical-grade antimicrobial peptides","volume":"22","author":"Chaudhary","year":"2024","journal-title":"Plant Biotechnol J"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib221","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-123879","article-title":"Chemical wastes in the peptide synthesis process and ways to reduce them","volume":"21","author":"Haji Abbasi Somehsaraie","year":"2022","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib222","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fmicb.2014.00341","article-title":"Recombinant protein expression in microbial systems","volume":"5","author":"Rosano","year":"2014","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib223","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am J Transl Res"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib224","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/antibiotics13121207","article-title":"Fusion partner facilitates expression of cell-penetrating peptide L2 in pichia pastoris","volume":"13","author":"Li","year":"2024","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s44222-023-00044-6","article-title":"Plant-based biopharmaceutical engineering","volume":"1","author":"Eidenberger","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.pharmr.2025.100104_bib226","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608401","article-title":"Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors","volume":"16","author":"Puig","year":"2025","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib227","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib228","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-025-03166-8","article-title":"Integrating synthetic polypeptides with innovative material forming techniques for advanced biomedical applications","volume":"23","author":"Kang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.pharmr.2025.100104_bib229","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.csbj.2023.05.003","article-title":"Advancing synthetic biology through cell-free protein synthesis","volume":"21","author":"Yue","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib230","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/antibiotics10080990","article-title":"Recent advances and challenges in nanodelivery systems for antimicrobial peptides (AMPs)","volume":"10","author":"Tang","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib231","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib232","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/antibiotics3040461","article-title":"Antimicrobial peptide resistance mechanisms of Gram-positive bacteria","volume":"3","author":"Nawrocki","year":"2014","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib233","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biom12020306","article-title":"An introduction to bacterial biofilms and their proteases, and their roles in host infection and immune evasion","volume":"12","author":"Ram\u00edrez-Larrota","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2025.100104_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1149418","article-title":"The culmination of multidrug-resistant efflux pumps vs. meager antibiotic arsenal era: urgent need for an improved new generation of EPIs","volume":"14","author":"Chetri","year":"2023","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib235","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/microorganisms8081222","article-title":"Targeting biofilms therapy: current research strategies and development hurdles","volume":"8","author":"Jiang","year":"2020","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib236","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/ijms20071781","article-title":"Two component regulatory systems and antibiotic resistance in Gram-negative pathogens","volume":"20","author":"Bhagirath","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100104_bib237","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.617784","article-title":"How bacterial adaptation to cystic fibrosis environment shapes interactions between Pseudomonas aeruginosa and Staphylococcus aureus","volume":"12","author":"Camus","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib238","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009443","article-title":"Bacteria primed by antimicrobial peptides develop tolerance and persist","volume":"17","author":"Rodr\u00edguez-Rojas","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.pharmr.2025.100104_bib239","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fmicb.2016.00381","article-title":"Induced bacterial cross-resistance toward host antimicrobial peptides: a worrying phenomenon","volume":"7","author":"Fleitas","year":"2016","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib240","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/microorganisms12071259","article-title":"Molecular mechanisms of bacterial resistance to antimicrobial peptides in the modern era: an updated review","volume":"12","author":"Tajer","year":"2024","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib241","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/MS9.0000000000003106","article-title":"Antimicrobial peptides: a promising frontier to combat antibiotic resistant pathogens","volume":"87","author":"Shriwastav","year":"2025","journal-title":"Ann Med Surg"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib242","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/biom8010004","article-title":"Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo","volume":"8","author":"Kumar","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2025.100104_bib243","series-title":"Chapter 7: antigen processing and presentation. Primer to the Immune Response","first-page":"161","year":"2014"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib244","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/antib13010016","article-title":"Immunogenicity and loss of effectiveness of biologic therapy for inflammatory bowel disease patients due to anti-drug antibody development","volume":"13","author":"Velikova","year":"2024","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41541-023-00705-y","article-title":"Modified influenza M158\u201366 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge","volume":"8","author":"Lanfermeijer","year":"2023","journal-title":"npj Vaccin"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib246","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Jetha","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib247","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3904\/kjim.2021.438","article-title":"Desensitization for the prevention of drug hypersensitivity reactions","volume":"37","author":"Kang","year":"2022","journal-title":"Korean J Intern Med"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib248","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185430","article-title":"Antimicrobial peptide developed with machine learning sequence optimization targets drug resistant Staphylococcus aureus in mice","volume":"135","author":"Mishra","year":"2025","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib249","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG antibodies and their biological impact on pegylated drugs: challenges and strategies for optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib250","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv"},{"issue":"16","key":"10.1016\/j.pharmr.2025.100104_bib251","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2174\/1381612821666150310102702","article-title":"Antimicrobial peptides and peptidomimetics\u2014potent therapeutic allies for staphylococcal infections","volume":"21","author":"Mohammad","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib252","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40824-022-00326-x","article-title":"Immunomodulatory biomaterials for implant-associated infections: from conventional to advanced therapeutic strategies","volume":"26","author":"Dong","year":"2022","journal-title":"Biomater Res"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100104_bib253","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.3390\/nu16213655","article-title":"IL-33 induces a switch in intestinal metabolites revealing the tryptophan pathway as a target for inducing allograft survival","volume":"16","author":"Pinto","year":"2024","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib254","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/antibiotics10121485","article-title":"Predicting antimicrobial activity at the target site: pharmacokinetic\/pharmacodynamic indices versus time\u2013kill approaches","volume":"10","author":"van Os","year":"2021","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib255","doi-asserted-by":"crossref","DOI":"10.4155\/fdd-2022-0005","article-title":"Overcoming the shortcomings of peptide-based therapeutics","volume":"4","author":"Lamers","year":"2022","journal-title":"Future Drug Discov"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib256","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17425247.2022.2051476","article-title":"Progress and limitations of oral peptide delivery as a potentially transformative therapy","volume":"19","author":"Tran","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib257","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1124\/dmd.119.086488","article-title":"Mechanisms influencing the pharmacokinetics and disposition of monoclonal antibodies and peptides","volume":"47","author":"Datta-Mannan","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib258","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with Gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib259","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/msb.2011.71","article-title":"Systematic exploration of synergistic drug pairs","volume":"7","author":"Cokol","year":"2011","journal-title":"Mol Syst Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib260","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/acsinfecdis.0c00001","article-title":"Multitarget approaches against multiresistant superbugs","volume":"6","author":"Gray","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib261","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2010.11.052","article-title":"Phenotypic landscape of a bacterial cell","volume":"144","author":"Nichols","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib262","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/jac\/dkv488","article-title":"Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK\/PD model","volume":"71","author":"Mohamed","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pharmr.2025.100104_bib263","first-page":"106","article-title":"Breaking barriers: the potential of nanosystems in antituberculosis therapy","volume":"39","author":"Carnero Canales","year":"2024","journal-title":"Bioact Mater"},{"issue":"13","key":"10.1016\/j.pharmr.2025.100104_bib264","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1039\/C4CS00387J","article-title":"Cell surface-based sensing with metallic nanoparticles","volume":"44","author":"Jiang","year":"2015","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1039\/C7CS00748E","article-title":"Combatting antibiotic-resistant bacteria using nanomaterials","volume":"48","author":"Gupta","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.pharmr.2025.100104_bib266","doi-asserted-by":"crossref","first-page":"0104","DOI":"10.34133\/bmef.0104","article-title":"Advancing nanotechnology: targeting biofilm-forming bacteria with antimicrobial peptides","volume":"6","author":"Campos","year":"2025","journal-title":"BME Front"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib267","doi-asserted-by":"crossref","first-page":"198","DOI":"10.24272\/j.issn.2095-8137.2018.070","article-title":"Effects of C-terminal amidation and heptapeptide ring on the biological activities and advanced structure of amurin-9KY, a novel antimicrobial peptide identified from the brown frog, Rana kunyuensis","volume":"40","author":"Zhang","year":"2019","journal-title":"Zool Res"},{"key":"10.1016\/j.pharmr.2025.100104_bib268","article-title":"Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier","volume":"56","author":"Werner","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pharmr.2025.100104_bib269","doi-asserted-by":"crossref","unstructured":"Shakya AK, Al-Sulaibi M, Naik RR, Nsairat H, Suboh S, Abulaila A. Review on PLGA polymer based nanoparticles with antimicrobial properties and their application in various medical conditions or infections. Polymers;15(17):3597. https:\/\/doi.org\/10.3390\/POLYM15173597","DOI":"10.3390\/polym15173597"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib270","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1039\/D2BM01878K","article-title":"Amphiphilic dendrimers against antibiotic resistance: light at the end of the tunnel?","volume":"11","author":"Galanakou","year":"2023","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib271","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsbiomaterials.1c01267","article-title":"Ovotransferrin antibacterial peptide coupling mesoporous silica nanoparticle as an effective antibiotic delivery system for treating bacterial infection in vivo","volume":"8","author":"Ma","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.pharmr.2025.100104_bib272","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3606765","article-title":"Advancements in the use of hydrogels for regenerative medicine: properties and biomedical applications","volume":"2022","author":"Revete","year":"2022","journal-title":"Int J Biomater"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib273","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.3390\/ijms24087563","article-title":"Recent advances in antimicrobial peptide hydrogels","volume":"24","author":"Copling","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib274","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/pharmaceutics16111468","article-title":"Peptide-based biomaterials for combatting infections and improving drug delivery","volume":"16","author":"Lombardi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.pharmr.2025.100104_bib275","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3390\/molecules25133048","article-title":"Towards robust delivery of antimicrobial peptides to combat bacterial resistance","volume":"25","author":"Drayton","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2019.05.006","article-title":"Activity and characterization of a pH-sensitive antimicrobial peptide","volume":"1861","author":"Hitchner","year":"2019","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"25","key":"10.1016\/j.pharmr.2025.100104_bib277","doi-asserted-by":"crossref","first-page":"22730","DOI":"10.1021\/acsami.9b04750","article-title":"Sustainable dual release of antibiotic and growth factor from pH-responsive uniform alginate composite microparticles to enhance wound healing","volume":"11","author":"Shi","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib278","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jfb16010024","article-title":"Biodegradable and stimuli-responsive nanomaterials for targeted drug delivery in autoimmune diseases","volume":"16","author":"Parvin","year":"2025","journal-title":"J Funct Biomater"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib279","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2544683","article-title":"Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: status quo and barrier-overcoming strategies","volume":"32","author":"Gao","year":"2025","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharmr.2025.100104_bib280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib281","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcis.2024.11.169","article-title":"Probing antimicrobial synergy by novel lipopeptides paired with antibiotics","volume":"681","author":"Liao","year":"2025","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib282","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","article-title":"Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges","volume":"23","author":"Zheng","year":"2025","journal-title":"J Transl Med"},{"issue":"19","key":"10.1016\/j.pharmr.2025.100104_bib283","article-title":"Unveiling mechanisms of antimicrobial peptide: actions beyond the membranes disruption","volume":"10","author":"K","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.pharmr.2025.100104_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100254","article-title":"Examining alternative approaches to antibiotic utilisation: a critical evaluation of phage therapy and antimicrobial peptides combination as potential alternatives","volume":"6","author":"Alisigwe","year":"2025","journal-title":"Microbe"},{"key":"10.1016\/j.pharmr.2025.100104_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2025.111454","article-title":"Alginate-pectin microparticles embedding self-assembling antimicrobial peptides and resveratrol for antimicrobial and anti-inflammatory applications","volume":"167","author":"Roque-Borda","year":"2025","journal-title":"Food Hydrocoll"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100104_bib286","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.3390\/molecules28186624","article-title":"Emerging applications of nanotechnology in healthcare and medicine","volume":"28","author":"Malik","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib287","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib288","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00022-5","article-title":"Nanoencapsulation enhances stability, release behavior, and antimicrobial properties of Sage and Thyme essential oils","volume":"15","author":"Fakhariha","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib289","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","article-title":"Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery","volume":"19","author":"Tenchov","year":"2025","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib290","first-page":"445","article-title":"Antimicrobial peptides therapy: an emerging alternative for treating drug-resistant bacteria","volume":"95","author":"Mba","year":"2022","journal-title":"Yale J Biol Med"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib291","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/antibiotics11030349","article-title":"Antimicrobial peptides: from design to clinical application","volume":"11","author":"Zhang","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.pharmr.2025.100104_bib292","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.563030","article-title":"D- and unnatural amino acid substituted antimicrobial peptides with improved proteolytic resistance and their proteolytic degradation characteristics","volume":"11","author":"Lu","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib293","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/s41598-023-29984-0","article-title":"The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III","volume":"13","author":"Tortorella","year":"2023","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib294","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3390\/ijms20102383","article-title":"A comprehensive review on current advances in peptide drug development and design","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib295","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1039\/C8SC03275K","article-title":"Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design","volume":"10","author":"Li","year":"2019","journal-title":"Chem Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib296","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/antibiotics12091400","article-title":"Peptide stapling applied to antimicrobial peptides","volume":"12","author":"Louren\u00e7o","year":"2023","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib297","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41587-019-0222-z","article-title":"Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice","volume":"37","author":"Mourtada","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"100","key":"10.1016\/j.pharmr.2025.100104_bib298","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1039\/D0CC06312F","article-title":"Hydrocarbon staple constructing highly efficient \u03b1-helix cell-penetrating peptides for intracellular cargo delivery","volume":"56","author":"Li","year":"2020","journal-title":"Chem Commun"},{"issue":"50","key":"10.1016\/j.pharmr.2025.100104_bib299","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1021\/acs.jafc.2c06588","article-title":"Butelase 1-mediated enzymatic cyclization of antimicrobial peptides: improvements on stability and bioactivity","volume":"70","author":"Zhao","year":"2022","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib300","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00018-022-04440-w","article-title":"A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens","volume":"79","author":"White","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib301","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-3011.1999.00052.x","article-title":"Solution stability of linear vs. cyclic RGD peptides","volume":"53","author":"Bogdanowich-Knipp","year":"1999","journal-title":"J Pept Res"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib302","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41589-023-01496-y","article-title":"De novo development of small cyclic peptides that are orally bioavailable","volume":"20","author":"Merz","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"19","key":"10.1016\/j.pharmr.2025.100104_bib303","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910821","article-title":"Enhancing antimicrobial peptide activity through modifications of charge, hydrophobicity, and structure","volume":"25","author":"Gagat","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib304","first-page":"1095","article-title":"Design methods for antimicrobial peptides with improved performance","volume":"44","author":"Mwangi","year":"2023","journal-title":"Zool Res"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib305","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/microorganisms11051129","article-title":"Advances in antimicrobial peptide discovery via machine learning and delivery via nanotechnology","volume":"11","author":"Sowers","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.pharmr.2025.100104_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquaculture.2023.739362","article-title":"D-amino acid peptides as antimicrobial agents against vibrio-associated diseases in aquaculture","volume":"569","author":"L\u00f3pez-Sanmart\u00edn","year":"2023","journal-title":"Aquaculture"},{"key":"10.1016\/j.pharmr.2025.100104_bib307","doi-asserted-by":"crossref","unstructured":"Cresti L, Cappello G, Pini A. Antimicrobial peptides towards clinical application\u2014a long history to be concluded. Int J Mol Sci.25(9):4870. https:\/\/doi.org\/10.3390\/IJMS25094870","DOI":"10.3390\/ijms25094870"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib308","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/jfb14110539","article-title":"Shaping the future of Antimicrobial Therapy: harnessing the power of antimicrobial peptides in biomedical applications","volume":"14","author":"Tripathi","year":"2023","journal-title":"J Funct Biomater"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib309","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-bioeng-010220-095711","article-title":"Engineering selectively targeting antimicrobial peptides","volume":"23","author":"Lei","year":"2021","journal-title":"Annu Rev Biomed Eng"},{"issue":"23","key":"10.1016\/j.pharmr.2025.100104_bib310","doi-asserted-by":"crossref","DOI":"10.1128\/aem.01617-22","article-title":"Incorporation of non-canonical amino acids into antimicrobial peptides: advances, challenges, and perspectives","volume":"88","author":"Du","year":"2022","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib311","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3560","article-title":"Non-canonical amino acid bioincorporation into antimicrobial peptides and its challenges","volume":"30","author":"Enninful","year":"2024","journal-title":"J Pept Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib312","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.3390\/molecules29112492","article-title":"Recent advances in amphipathic peptidomimetics as antimicrobial agents to combat drug resistance","volume":"29","author":"Su","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100104_bib313","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1304997","article-title":"Editorial: improving antimicrobial peptides translational potential through peptidomimetics","volume":"14","author":"Angeles-Boza","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib314","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111636","article-title":"Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity","volume":"182","author":"Zhong","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100104_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105453","article-title":"Effect of N-methylated and fatty acid conjugation on analogs of antimicrobial peptide Anoplin","volume":"152","author":"Liu","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"33","key":"10.1016\/j.pharmr.2025.100104_bib316","doi-asserted-by":"crossref","first-page":"21359","DOI":"10.1021\/acsomega.1c01854","article-title":"Tuning the activity of Anoplin by Dendrimerization of lysine and lipidation of the N-terminal","volume":"6","author":"Gou","year":"2021","journal-title":"ACS Omega"},{"issue":"32","key":"10.1016\/j.pharmr.2025.100104_bib317","doi-asserted-by":"crossref","first-page":"28238","DOI":"10.1021\/acsomega.2c02570","article-title":"Conjugation of CTX(Ile 21)-ha antimicrobial peptides to chitosan ultrathin films by N\u2014acetylcysteine improves peptide physicochemical properties and enhances biological activity","volume":"7","author":"Roque-Borda","year":"2022","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib318","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1021\/bi00010a034","article-title":"Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2","volume":"34","author":"Matsuzaki","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100104_bib319","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41522-017-0017-2","article-title":"Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound","volume":"3","author":"Chung","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib320","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/AAC.49.8.3208-3216.2005","article-title":"Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications","volume":"49","author":"Deslouches","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib321","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/acsmedchemlett.4c00375","article-title":"Hybrids of membrane-translocating antimicrobial peptides show enhanced activity through membrane permeabilization","volume":"15","author":"Trevellin","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100104_bib322","article-title":"A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants","volume":"6","author":"Kadirvelu","year":"2024","journal-title":"Curr Res Microb Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib323","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12941-024-00701-7","article-title":"Dual-function antimicrobial-antibiofilm peptide hybrid to tackle biofilm-forming Staphylococcus epidermidis","volume":"23","author":"Wongchai","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib324","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1040841X.2020.1842325","article-title":"Ways to control harmful biofilms: prevention, inhibition, and eradication","volume":"47","author":"Yin","year":"2021","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12864-022-08310-4","article-title":"AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens","volume":"23","author":"Li","year":"2022","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib326","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/acsptsci.0c00001","article-title":"Synthetic antimicrobial peptide tuning permits membrane disruption and interpeptide synergy","volume":"3","author":"Fields","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib327","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.01358-23","article-title":"PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides","volume":"9","author":"Ramos-Llorens","year":"2024","journal-title":"mSystems"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib328","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1556\/1886.2024.00035","article-title":"Methods for screening and evaluation of antimicrobial activity: a review of protocols, advantages, and limitations","volume":"14","author":"Hossain","year":"2024","journal-title":"Eur J Microbiol Immunol"},{"key":"10.1016\/j.pharmr.2025.100104_bib329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1855-4_1","article-title":"Machine learning prediction of antimicrobial peptides","volume":"2405","author":"Wang","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib330","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/jfb15110320","article-title":"Innovative strategies and methodologies in antimicrobial peptide design","volume":"15","author":"Verma","year":"2024","journal-title":"J Funct Biomater"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib331","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/acs.jcim.1c00175","article-title":"Computational methods and tools in antimicrobial peptide research","volume":"61","author":"Aronica","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib332","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1039\/D3DD00186E","article-title":"Progress and future of the computational design of antimicrobial peptides (AMPs): bio-inspired functional molecules","volume":"3","author":"Nedyalkova","year":"2024","journal-title":"Digit Discov"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib333","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.actbio.2013.08.043","article-title":"Design of imperfectly amphipathic \u03b1-helical antimicrobial peptides with enhanced cell selectivity","volume":"10","author":"Zhu","year":"2014","journal-title":"Acta Biomater"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib334","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5088","article-title":"De novo synthetic antimicrobial peptide design with a recurrent neural network","volume":"33","author":"Li","year":"2024","journal-title":"Protein Sci"},{"issue":"D1","key":"10.1016\/j.pharmr.2025.100104_bib335","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gkac933","article-title":"CAMPR4: a database of natural and synthetic antimicrobial peptides","volume":"51","author":"Gawde","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib336","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183177","article-title":"Rationally designed antimicrobial peptides: insight into the mechanism of eleven residue peptides against microbial infections","volume":"1862","author":"Pandit","year":"2020","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib337","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1038\/s41598-019-41005-7","article-title":"A peptide-nanoparticle system with improved efficacy against multidrug resistant bacteria","volume":"9","author":"Pal","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib338","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s12602-024-10402-4","article-title":"Progress in the identification and design of novel antimicrobial peptides against pathogenic microorganisms","volume":"17","author":"Sun","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib339","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.jcim.0c01441","article-title":"AMPGAN v2: machine learning-guided design of antimicrobial peptides","volume":"61","author":"Van Oort","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"33","key":"10.1016\/j.pharmr.2025.100104_bib340","doi-asserted-by":"crossref","first-page":"20746","DOI":"10.1021\/acsomega.0c00442","article-title":"Variational autoencoder for generation of antimicrobial peptides","volume":"5","author":"Dean","year":"2020","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib341","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41467-023-36994-z","article-title":"Discovering highly potent antimicrobial peptides with deep generative model HydrAMP","volume":"14","author":"Szymczak","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib342","first-page":"7","article-title":"Antimicrobial resistance crisis: could artificial intelligence be the solution?","volume":"11","author":"Liu","year":"2024","journal-title":"Mil Med Res"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib343","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12539-024-00612-3","article-title":"Machine learning accelerates de novo design of antimicrobial peptides","volume":"16","author":"Yin","year":"2024","journal-title":"Interdiscip Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib344","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s44222-024-00152-x","article-title":"Machine learning for antimicrobial peptide identification and design","volume":"2","author":"Wan","year":"2024","journal-title":"Nat Rev Bioeng"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib345","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41551-024-01201-x","article-title":"Deep-learning-enabled antibiotic discovery through molecular de-extinction","volume":"8","author":"Wan","year":"2024","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib346","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/00003246-200107001-00039","article-title":"Bactericidal\/permeability-increasing protein\u2014Lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia","volume":"29","author":"Giroir","year":"2001","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib347","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib348","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2125.2001.01397-3.x","article-title":"Points to consider on switching between superiority and non-inferiority","volume":"52","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib349","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/593185","article-title":"Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream","volume":"47","author":"Lipsky","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"A","key":"10.1016\/j.pharmr.2025.100104_bib350","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.ijbiomac.2022.04.130","article-title":"Tiger 17 and pexiganan as antimicrobial and hemostatic boosters of cellulose acetate-containing poly(vinyl alcohol) electrospun mats for potential wound care purposes","volume":"209","author":"Teixeira","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharmr.2025.100104_bib351","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3389\/fmicb.2020.01669","article-title":"The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design","volume":"11","author":"Le\u00f3n-Buitimea","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100104_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107524","article-title":"Important structural features of antimicrobial peptides towards specific activity: trends in the development of efficient therapeutics","volume":"149","author":"Fathi","year":"2024","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib353","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/med.21879","article-title":"Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections","volume":"42","author":"Zhu","year":"2022","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmr.2025.100104_bib354","series-title":"T\u00ecm Tr\u00ean Google","article-title":"No time to wait: securing the future from drug-resistant infections","year":"2019"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib355","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","article-title":"Antibiotic resistance","volume":"10","author":"Frieri","year":"2017","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.pharmr.2025.100104_bib356","doi-asserted-by":"crossref","DOI":"10.1038\/srep37908","article-title":"Lipid-II independent antimicrobial mechanism of nisin depends on its crowding and degree of oligomerization","volume":"6","author":"Prince","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib357","doi-asserted-by":"crossref","first-page":"15","DOI":"10.15586\/jkcvhl.2015.21","article-title":"Gramicidin A: a new mission for an old antibiotic","volume":"2","author":"David","year":"2015","journal-title":"J Kidney Cancer VHL"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib358","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0019-2791(76)90181-6","article-title":"Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides","volume":"13","author":"Morrison","year":"1976","journal-title":"Immunochemistry"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib359","article-title":"Antibacterial mechanisms of polymyxin and bacterial resistance","volume":"2015","author":"Yu","year":"2015","journal-title":"BioMed Res Int"},{"issue":"24","key":"10.1016\/j.pharmr.2025.100104_bib360","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","article-title":"The action mechanism of daptomycin","volume":"24","author":"Taylor","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2025.100104_bib361","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2007.07.005","article-title":"The bactericidal\/permeability-increasing protein (BPI) in infection and inflammatory disease","volume":"384","author":"Schultz","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmr.2025.100104_bib362","author":"Orlov"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib363","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1128\/AAC.01087-15","article-title":"Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile","volume":"59","author":"Alam","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib364","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.bbamem.2008.10.009","article-title":"Structure, membrane orientation, mechanism, and function of pexiganan \u2014 a highly potent antimicrobial peptide designed from magainin","volume":"1788","author":"Gottler","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100104_bib365","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tibtech.2009.07.004","article-title":"Potential of immunomodulatory host defense peptides as novel anti-infectives","volume":"27","author":"Easton","year":"2009","journal-title":"Trends Biotechnol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib366","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2009.05.003","article-title":"Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models","volume":"34","author":"Rubinchik","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pharmr.2025.100104_bib367","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbiotec.2016.10.010","article-title":"Dusquetide: a novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study","volume":"239","author":"Kudrimoti","year":"2016","journal-title":"J Biotechnol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib368","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14787210.4.6.939","article-title":"Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent","volume":"4","author":"Fulco","year":"2006","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100104_bib369","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamasurg.2013.4841","article-title":"A novel drug for treatment of necrotizing soft-tissue infections: a randomized clinical trial","volume":"149","author":"Bulger","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pharmr.2025.100104_bib370","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110712","article-title":"Synthesis and characterization of cecropin peptide-based silver nanocomposites: its antibacterial activity and mode of action","volume":"110","author":"Muchintala","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.pharmr.2025.100104_bib371","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127822","article-title":"Antimicrobial peptides: opportunities and challenges in overcoming resistance","volume":"286","author":"Bucataru","year":"2024","journal-title":"Microbiol Res"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib372","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215703","article-title":"Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability","volume":"14","author":"Yasir","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100104_bib373","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.03053","article-title":"Mechanism of action of surface immobilized antimicrobial peptides against Pseudomonas aeruginosa","volume":"10","author":"Yasir","year":"2020","journal-title":"Front Microbiol"},{"issue":"5968","key":"10.1016\/j.pharmr.2025.100104_bib374","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1182749","article-title":"Peptidomimetic antibiotics target outer-membrane biogenesis in pseudomonas aeruginosa","volume":"327","author":"Srinivas","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib375","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/AAC.06354-11","article-title":"Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571","volume":"56","author":"Leeds","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib376","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.MIB.0000172807.26748.16","article-title":"Rdp58 is a novel and potentially effective oral therapy for ulcerative colitis","volume":"11","author":"Travis","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib377","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/AAC.01199-07","article-title":"The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding","volume":"52","author":"Woong","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100104_bib378","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000490772","article-title":"Immunomodulatory and kidney-protective effects of the human chorionic gonadotropin derivate EA-230","volume":"140","author":"Van Groenendael","year":"2018","journal-title":"Nephron"},{"issue":"24","key":"10.1016\/j.pharmr.2025.100104_bib379","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1073\/pnas.1506207112","article-title":"Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology","volume":"112","author":"Guo","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100104_bib380","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/mmy\/myaa015","article-title":"NP. NP213 (Novexatin\u00ae): a unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile","volume":"58","author":"Mercer","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.pharmr.2025.100104_bib381","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fcimb.2019.00174","article-title":"Characterization of the in vitro, ex vivo, and in vivo Efficacy of the antimicrobial Peptide DPK-060 Used for Topical Treatment","volume":"9","author":"H\u00e5kansson","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib382","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/AAC.00827-15","volume":"59","author":"Peyrusson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib383","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/03009734.2016.1230157","article-title":"PXL01 in sodium hyaluronate results in increased PRG4 expression: a potential mechanism for anti-adhesion","volume":"122","author":"Edsfeldt","year":"2017","journal-title":"Ups J Med Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100104_bib384","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.2008.97","article-title":"AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality","volume":"73","author":"Doi","year":"2008","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib385","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1128\/AAC.02955-14","article-title":"Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16","volume":"58","author":"Mensa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib386","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkp299","article-title":"XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity","volume":"64","author":"Ooi","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib387","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.1989.tb01415.x","article-title":"Enhancement of Candida albicans killing activity of separated human epidermal cells by alpha-melanocyte stimulating hormone","volume":"121","author":"Csato","year":"1989","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib388","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/molecules21050616","article-title":"Anti-inflammatory applications of melittin, a major component of bee venom: detailed mechanism of action and adverse effects","volume":"21","author":"Lee","year":"2016","journal-title":"Molecules"},{"issue":"10 Pt A","key":"10.1016\/j.pharmr.2025.100104_bib389","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.bbamem.2015.07.010","article-title":"Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systems","volume":"1848","author":"Malanovic","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"10.1016\/j.pharmr.2025.100104_bib390","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1021\/jm200450h","article-title":"A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption","volume":"54","author":"Isaksson","year":"2011","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100104_bib391","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/IAI.69.3.1469-1476.2001","article-title":"Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria","volume":"69","author":"Nibbering","year":"2001","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.pharmr.2025.100104_bib392","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1021\/acs.joc.7b02318","article-title":"Total synthesis and biological mode of action of WAP-8294A2: a menaquinone-targeting antibiotic","volume":"83","author":"Itoh","year":"2018","journal-title":"J Org Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib393","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.01040-08","article-title":"The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate","volume":"53","author":"Schneider","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib394","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dks359","article-title":"Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection","volume":"68","author":"Crowther","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib395","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/JB.186.9.2891-2896.2004","article-title":"Origin and diversity of alginate lyases of families PL-5 and \u22127 in Sphingomonas sp. strain A1","volume":"186","author":"Miyake","year":"2004","journal-title":"J Bacteriol"},{"issue":"52","key":"10.1016\/j.pharmr.2025.100104_bib396","doi-asserted-by":"crossref","first-page":"36007","DOI":"10.1074\/jbc.C109.073627","article-title":"Sequestosome-1\/p62 is the key intracellular target of innate defense regulator peptide","volume":"284","author":"Yu","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib397","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/13543776.2020.1851679","article-title":"Antimicrobial peptides (AMPs): a patent review (2015\u20132020)","volume":"30","author":"Annunziato","year":"2020","journal-title":"Expert Opin Ther Pat"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100104_bib398","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111401","article-title":"Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities","volume":"22","author":"Luo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib399","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3390\/ijms23052499","article-title":"Immunomodulatory and allergenic properties of antimicrobial peptides","volume":"23","author":"Guryanova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100104_bib400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1119574","article-title":"Antimicrobial peptides\u2019 immune modulation role in intracellular bacterial infection","volume":"14","author":"Duarte-Mata","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib401","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/antibiotics13040343","article-title":"A comprehensive review of recent research into the effects of antimicrobial peptides on biofilms-January 2020 to September 2023","volume":"13","author":"Fontanot","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib402","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/2211550111201010072","article-title":"Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering","volume":"1","author":"Wang","year":"2012","journal-title":"Curr Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100104_bib403","doi-asserted-by":"crossref","unstructured":"Bellavita R, Braccia S, Galdiero S, Falanga A. Glycosylation and lipidation strategies: approaches for improving antimicrobial peptide efficacy. Pharmaceuticals;16(3):439. https:\/\/doi.org\/10.3390\/PH16030439","DOI":"10.3390\/ph16030439"},{"key":"10.1016\/j.pharmr.2025.100104_bib404","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.888540","article-title":"Editorial: antimicrobial peptides: molecular design, structure-function relationship, and biosynthesis optimization","volume":"13","author":"Hao","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100104_bib405","doi-asserted-by":"crossref","first-page":"74","DOI":"10.32607\/actanaturae.11878","article-title":"Creation of recombinant biocontrol agents by genetic programming of yeast","volume":"15","author":"Pipiya","year":"2023","journal-title":"Acta Nat"},{"key":"10.1016\/j.pharmr.2025.100104_bib406","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2021.778645","article-title":"Drug delivery systems for the oral administration of antimicrobial peptides: promising tools to treat infectious diseases","volume":"3","author":"Deshayes","year":"2022","journal-title":"Front Med Technol"},{"issue":"19","key":"10.1016\/j.pharmr.2025.100104_bib407","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.3390\/molecules27196640","article-title":"S100 proteins as novel therapeutic targets in psoriasis and other autoimmune diseases","volume":"27","author":"Kurpet","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100104_bib408","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3390\/microorganisms12091920","article-title":"An overview of the recent advances in antimicrobial resistance","volume":"12","author":"Oliveira","year":"2024","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100104_bib409","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/cid\/ciz1039","article-title":"Transferrable market exclusivity extensions to promote antibiotic development: an economic analysis","volume":"71","author":"Rome","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100104_bib410","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ja.2017.124","article-title":"Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps","volume":"70","author":"Simpkin","year":"2017","journal-title":"J Antibiot"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100104_bib411","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/antibiotics11050667","article-title":"An overview of antimicrobial stewardship optimization: the use of antibiotics in humans and animals to prevent resistance","volume":"11","author":"Rahman","year":"2022","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100104_bib412","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.emc.2018.06.012","article-title":"Antimicrobial stewardship in the emergency department","volume":"36","author":"Pulia","year":"2018","journal-title":"Emerg Med Clin North Am"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725075131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725075131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:15:17Z","timestamp":1777446917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699725075131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":410,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0031699725075131"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100104","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100104"}}